● Recruiting

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

Condition: Higher-risk Myelodysplastic Syndromes · Sponsor: Akeso

PhasePhase 2

Planned participants90

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy and safety of AK117 or placebo, combined with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndromes (HR-MDS).

This description comes directly from the study's public registry record.

Talk to the study team

Wenting Li, MD · (+86)18116403289 · wenting01.li@akesobio.com

Always discuss trial participation with your own doctor first.

Locations (15)

UCLA Ronald Reagan Medical Center	Los Angeles, California, United States	Recruiting
Rocky Mountain Cancer Centers	Aurora, Colorado, United States	Recruiting
Yale Cancer Center	New Haven, Connecticut, United States	Recruiting
Mid Florida Hematology and Oncology Center	Orange City, Florida, United States	Recruiting
American Oncology Partners, PA (The Center for Cancer and Blood Disorders-Bethesda)	Bethesda, Maryland, United States	Recruiting
Maryland Oncology-Columbia	Columbia, Maryland, United States	Recruiting
Washington University School of Medicine in St. Louis	St Louis, Missouri, United States	Recruiting
Montefiore Einstein Comprehensive Cancer Center	The Bronx, New York, United States	Recruiting
UNC Lineberger Comprehensive Cancer Center	Chapel Hill, North Carolina, United States	Recruiting
Gabrail Cancer Center	Canton, Ohio, United States	Recruiting
Ohio State University	Columbus, Ohio, United States	Recruiting
Oncology Associates of Oregon	Eugene, Oregon, United States	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06196203